Autism Spectrum Disorder: Insights Into Convergent Mechanisms from Transcriptomics
Total Page：16
File Type：pdf, Size：1020Kb
REVIEWS Autism spectrum disorder: insights into convergent mechanisms from transcriptomics Mathieu Quesnel-Vallières 1,2,3,4*, Robert J. Weatheritt3,5, Sabine P. Cordes1,2* and Benjamin J. Blencowe1,3* Abstract | Heredity has a major role in autism spectrum disorder (ASD), yet underlying causal genetic variants have been defined only in a fairly small subset of cases. The enormous genetic heterogeneity associated with ASD emphasizes the importance of identifying convergent pathways and molecular mechanisms that are responsible for this disorder. We review how recent transcriptomic analyses have transformed our understanding of pathway convergence in ASD. In particular, deep RNA sequencing coupled with downstream investigations has revealed that a substantial fraction of autistic brains possess distinct transcriptomic signatures. These signatures are in part a consequence of altered neuronal activity and have a particular impact on pre-mRNA alternative splicing patterns. Autism spectrum disorder (ASD) encompasses a highly associated with this disorder contribute to brain develop- heterogeneous set of neurodevelopmental conditions ment, neuronal activity, signalling and transcription regu- that are semantically and clinically grouped because lation7–11. Moreover, synaptic function, translation and they share common behavioural hallmarks, including WNT signalling have been identified as three major cellu- abnormal social interactions, impaired communication lar pathways commonly affected by mutations in diverse skills and repetitive or stereotypical behaviour. A high ASD-related genes12–14 (Fig. 1), and altered WNT pathway concordance rate of ASD in monozygotic twins1,2 and signalling is considered to have a key role in the aetiology 3 15,16 1Department of Molecular increased recurrence among siblings confirmed that the of autism . The convergence of dozens of risk genes Genetics, University of aetiology of ASD bears a strong genetic component, with on common molecular pathways can help explain how Toronto, Toronto, Ontario, heritability estimated to be ~50%4,5. However, the genetic a genetically heterogeneous population of individuals Canada. causes of ASD are varied and often complex, even in displays similar behavioural features. Moreover, during 2Lunenfeld-Tanenbaum individual cases. This genetic complexity, paired with fetal and childhood development, and throughout adult Research Institute, Mount variable presentation, including between monozygotic life, environmental factors and neuronal activity modu- Sinai Hospital, Toronto, 9,17 Ontario, Canada. twins, can complicate diagnosis and has hindered the late all three of these pathways . Thus, in ASD, altering 3Donnelly Centre, University development of therapies. Moreover, even for disorders these sensitive, dynamic processes that normally estab- of Toronto, Toronto, Ontario, such as fragile X syndrome and Rett syndrome, for which lish and sustain neuronal functions can activate feedback Canada. ASD-causing genetic alterations have been identified, a and feedforward mechanisms that further exacerbate 4Department of Biochemistry successful treatment has not yet been developed. any disturbances in cellular regulatory networks and and Biophysics and On the basis of clinical presentation, 4–5% of ASD contribute to the progression and pathogenesis of ASD. Department of Genetics, cases can be defined as carrying mutations in known These observations raise the following question: University of Pennsylvania, 6 Philadelphia, PA, USA. ASD-causing loci, such as fragile X or Rett syndrome which processes controlled by these pathways might (BOx 1) 5EMBL Australia, Garvan . About 25% of ASD individuals have been found contribute to ASD pathogenesis? Indeed, the three Institute of Medical Research, to carry variations that can be detected cytogenetically, main pathways implicated control large programmes of Darlinghurst, New South such as chromosome 15q duplications (Dup15q syn- cellular events. For example, on their own or together, Wales, Australia. drome; BOx 1) or by sequence-based analyses of known defective synaptogenesis or synaptic function, altered *e-mail: mathieu. or candidate ASD genes. However, for ~75% of patients WNT signalling during brain development and mis- quesnel-vallieres@ with ASD the causes are unknown6. This majority of regulated translation in neurons can all influence neu- pennmedicine.upenn.edu; 18–20 [email protected]; cases, referred to as having nonsyndromic idiopathic ronal circuit formation and activity , which in turn [email protected] ASD, is the focus of this Review. can trigger signalling cascades by transmitting action https://doi.org/10.1038/ Despite the profound genetic complexity of ASD, potentials. Ultimately, changes in neuronal activity mod- s41576-018-0066-2 enrichment analyses have revealed that genes significantly ulate specific transcriptional programmes comprising NATURE REVIEWS | GENETICS VOLUME 20 | JANUARY 2019 | 51 REVIEWS Box 1 | Syndromic ASD and transcriptomic analyses repertoires of gene products expressed in the nervous system, are also highly responsive to changes in synap- Limited transcriptomic analyses of human cultured neurons or post-mortem brains tic function and neuronal activity23–27. Thus, although have been performed for the following syndromes associated with autism spectrum genetic studies have identified specific cellular pathways disorder (ASD). that are targeted by mutations in diverse ASD-related Fragile X syndrome genes, complementary approaches are required to cap- 129 Fragile X syndrome (FXS) is responsible for 1–2% of all diagnosed cases of ASD . FXS ture the consequent changes that occur in downstream occurs when a CGG triplet repeat exceeds 200 or more copies in the 5ʹ untranslated processes, such as transcription and pre-mRNA splicing. region of the FMR1 gene. This triplet repeat expansion causes epigenetic silencing of Transcriptomic analyses can provide insights into how FMR1 gene expression as well as RNA toxic gain of function, toxic repeat-associated non-ATG translation and somatic instability. The FMR1 gene encodes fragile X mental diverse ASD-causing genetic mechanisms or risk factors retardation protein 1 (FMRP), an RNA-binding protein that regulates the transport, might result in shared behavioural outcomes. The advent stability and local protein synthesis of hundreds of mRNAs in the mammalian brain130. of microarrays, followed by high-throughput RNA Analyses of Fmr1 loss-of-function mouse models have confirmed the importance of sequencing (RNA-seq), has enabled whole-transcriptome FMRP in neuronal development and function as well as behaviour but cannot assess the analysis (Fig. 2). These approaches yield information possible additional contribution of trinucleotide repeat expansion mechanisms131. about transcript abundance and can be applied to mRNA Analyses of the human FXS neural transcriptome have been limited. A microarray- and small or long non-coding RNA (lncRNA) tran- based analysis of the transcriptomes of neurons differen tiated from induced pluripotent scripts. RNA-seq data can also be used to interrogate the stem cells (iPSCs) from patients with FXS revealed aberrant regulation of neural nature and frequency of alternative splicing events in differentiation and axon guidance genes132. different samples. Rett syndrome In this Review, we highlight how transcriptome profil- X-Linked Rett syndrome is typically caused by mutations in methyl-CpG binding protein 2 ing in different brain regions has revealed ASD-associated 133 134 (MECP2) and leads to ASD in 61% of affected girls . Boys with Rett syndrome signatures of mRNA and non-coding RNA expression frequently die shortly after birth. MECP2 binds DNA at methylated cytosines and is as well as alternative splicing. We also highlight the thought to have a role in chromatin remodelling and thus transcriptional regulation135,136. The consequences of MECP2 loss have been explored extensively in mice lacking Mecp2, importance of neuronal activity in the control of these which display the neurobiological deficits seen in patients with Rett syndrome137. regulatory programmes and discuss how they fit within Transcriptomic analyses of post-mortem brain samples of patients with Rett syndrome current models of ASD pathogenesis stemming from using RNA sequencing (RNA-seq) and microarrays have revealed downregulation genomic investigations. Finally, we discuss new mecha- of neurodevelopmental genes and overexpression of neuroinflammatory genes in nistic insights into convergent molecular mecha nisms the forebrain and cerebellum138,139. One study reported an overexpression of that have emerged from transcriptomic investigations of neuroinflammatory genes138, which was not observed in the other study139. ASD and how these mechanisms link major pathways underlying neurodevelopmental disorders. Chromosome 15 deletion and duplication syndromes Deletion and duplication events that affect an imprinted region on chromosome Gene expression in the ASD brain 15q11–13 are responsible for a group of neurodevelopmental disorders associated with ASD, including Prader–Willi syndrome and Angelman syndrome. Of patients with Transcriptomic analyses have focused mostly on three 28 Prader–Willi syndrome140, 26.7% meet diagnostic criteria for ASD, as do 34% of patients brain regions suggested to be implicated in ASD : the with Angelman syndrome134. Duplications of the chromosome 15q11–13.1 region prefrontal cortex, the superior temporal cortex and (Dup15q) are